[
    [
        {
            "time": "",
            "original_text": "沃森生物：公司产品生产和批签发的工作均在正常开展",
            "features": {
                "keywords": [
                    "沃森生物",
                    "产品生产",
                    "批签发",
                    "正常开展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司产品生产和批签发的工作均在正常开展",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：新冠mRNA疫苗国际多中心三期临床试验的相关工作正在墨西哥、印度尼西亚等地同步展开",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新冠mRNA疫苗",
                    "国际多中心",
                    "三期临床试验",
                    "墨西哥",
                    "印度尼西亚"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：新冠mRNA疫苗国际多中心三期临床试验的相关工作正在墨西哥、印度尼西亚等地同步展开",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司13价肺炎结合疫苗出口摩洛哥的事宜在按照当地政府的政策和流程不断推进中",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎结合疫苗",
                    "出口",
                    "摩洛哥",
                    "政策",
                    "流程"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗出口"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：公司13价肺炎结合疫苗出口摩洛哥的事宜在按照当地政府的政策和流程不断推进中",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]